Join
Live feed
·
PRReleasevia Quantisnow
Pharvaris N.V. logo

Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference

ByQuantisnow·Wall Street's wire, on your screen.
PHVS· Pharvaris N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHVS (Pharvaris N.V.) and more on Quantisnow.